Overdiagnosis and too much medicine in a world of crises

Thomas Kühlein(Universitätsklinikum Erlangen), Martin Scherer(Universität Hamburg), Anne Møller(University of Copenhagen), Steven Woloshin(Dartmouth College), Tessa Copp(The University of Sydney), Minna Johansson, Karsten Juhl Jørgensen(University of Southern Denmark), Helen Macdonald, Barnett S. Kramer(Norwich University), Kirsten McCaffery(New South Wales Department of Health), John Brodersen(University of Copenhagen)
BMJ
August 12, 2023
10.1136/bmj.p1865
Cited by 28

Related Papers

The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round
|Journal of Thoracic Oncology|2009|440
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
|Thorax|2012|391
Overdiagnosis: what it is and what it isn’t
|BMJ Evidence-Based Medicine|2018|368
Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling
|American Journal of Respiratory and Critical Care Medicine|2015|343
Long-Term Psychosocial Consequences of False-Positive Screening Mammography
|The Annals of Family Medicine|2013|342